All Relations between Neuromyelitis Optica and oligodendrocyte

Publication Sentence Publish Date Extraction Date Species
S Jarius, M Ringelstein, K Schanda, K Ruprecht, M Korporal-Kuhnke, A Viehöver, M W Hümmert, P Schindler, V Endmayr, M Gastaldi, C Trebst, D Franciotta, O Aktas, R Höftberger, J Haas, L Komorowski, F Paul, M Reindl, B Wildeman. Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity-a potential diagnostic pitfall in patients with MOG-EM/MOGAD. Journal of neurology. 2024-04-12. PMID:38609667. myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (mog-em; also termed mog antibody-associated disease, mogad) is the most important differential diagnosis of both multiple sclerosis and neuromyelitis optica spectrum disorders. 2024-04-12 2024-04-15 Not clear
Amna Siddiqui, Dylan Ross, Ronak H Jani, Vikram C Prabhu, Shelly Lo, Derek A Wainwright, Stasia Rouse, Tamer Refaat, Yirong Zhu, Jigisha P Thakka. Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Clinical & experimental neuroimmunology. vol 15. issue 1. 2024-04-10. PMID:38595690. cerebrospinal fluid was positive for neuromyelitis optica immunoglobulin g antibody anti-aquaporin-4, and autoimmune myelopathy panel was positive for myelin oligodendrocyte glycoprotein antibody. 2024-04-10 2024-04-12 Not clear
Amna Siddiqui, Dylan Ross, Ronak H Jani, Vikram C Prabhu, Shelly Lo, Derek A Wainwright, Stasia Rouse, Tamer Refaat, Yirong Zhu, Jigisha P Thakka. Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Clinical & experimental neuroimmunology. vol 15. issue 1. 2024-04-10. PMID:38595690. this case shows that these antibodies can occur concurrently and cause clinical features, such as both neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease, in a patient with a singular type of cancer. 2024-04-10 2024-04-12 Not clear
Miyo K Chatanaka, Lisa M Avery, Maria D Pasic, Shanthan Sithravadivel, Dalia Rotstein, Catherine Demos, Rachel Cohen, Taron Gorham, Mingyue Wang, Martin Stengelin, Anu Mathew, George Sigal, Jacob Wohlstadter, Ioannis Prassas, Eleftherios P Diamandi. The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies. Clinical proteomics. vol 21. issue 1. 2024-04-08. PMID:38580905. certain demyelinating disorders, such as neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) exhibit serum autoantibodies against aquaporin-4 (αaqp4) and myelin oligodendrocyte glycoprotein (αmog). 2024-04-08 2024-04-10 Not clear
Eun Bin Cho, Ju-Hong Min, Patrick Waters, Miyoung Jeon, Eun-Seon Ju, Ho Jin Kim, Su-Hyun Kim, Ha Young Shin, Sa-Yoon Kang, Young-Min Lim, Sun-Young Oh, Hye Lim Lee, Eunhee Sohn, Sang-Soo Lee, Jeeyoung Oh, Sunyoung Kim, So-Young Huh, Joong-Yang Cho, Jin Myoung Seok, Byung-Jo Kim, Byoung Joon Ki. Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder. Frontiers in immunology. vol 15. 2024-04-05. PMID:38576611. myelin oligodendrocyte glycoprotein antibody (mog) immunoglobulin g (igg)-associated disease (mogad) has clinical and pathophysiological features that are similar to but distinct from those of aquaporin-4 antibody (aqp4-igg)-positive neuromyelitis optica spectrum disorders (aqp4-nmosd). 2024-04-05 2024-04-07 Not clear
Christina Kazzi, Rubina Alpitsis, Terence J O'Brien, Charles B Malpas, Mastura Moni. Cognitive and psychopathological features of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease: A narrative review. Multiple sclerosis and related disorders. vol 85. 2024-04-04. PMID:38574722. cognitive and psychopathological features of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease: a narrative review. 2024-04-04 2024-04-07 Not clear
Christina Kazzi, Rubina Alpitsis, Terence J O'Brien, Charles B Malpas, Mastura Moni. Cognitive and psychopathological features of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease: A narrative review. Multiple sclerosis and related disorders. vol 85. 2024-04-04. PMID:38574722. this review discusses the current understanding of the cognitive and psychological features of neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). 2024-04-04 2024-04-07 Not clear
John H Rees, Torge Rempe, Ibrahim Sacit Tuna, Mayra Montalvo Perero, Shyamsunder Sabat, Tara Massini, Joseph M Yett. Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Magnetic resonance imaging clinics of North America. vol 32. issue 2. 2024-03-30. PMID:38555139. neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease. 2024-03-30 2024-04-02 Not clear
John H Rees, Torge Rempe, Ibrahim Sacit Tuna, Mayra Montalvo Perero, Shyamsunder Sabat, Tara Massini, Joseph M Yett. Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Magnetic resonance imaging clinics of North America. vol 32. issue 2. 2024-03-30. PMID:38555139. within the last 20 years, specific scientific advances have occurred leading to more accurate diagnosis and differentiation of several of these conditions including, neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody disease. 2024-03-30 2024-04-02 Not clear
Miguel Leal Rato, Bo Chen, Anna Francis, Silvia Messina, Madalina Miron, Yvonne Sharawakanda, Eoin O'Sullivan, Sarah Cooper, Leonora Fisniku, Christopher Halfpenny, Roswell Martin, Jeremy Hobart, Waqar Rashid, Cheryl Hemingway, Victoria Williams, Yael Hacohen, Ruth Dobson, Sithara Ramdas, Maria Isabel Leite, Jacqueline Palace, Ruth Geralde. A study of referral bias in NMOSD and MOGAD cohorts. Multiple sclerosis and related disorders. vol 85. 2024-03-29. PMID:38552551. neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) are rare disorders often seen in highly specialized services or tertiary centres. 2024-03-29 2024-04-01 Not clear
Özdem Ertürk Çetin, İpek Güngör Doğan, Ümit Zanapalioğlu, Feyzullah Yadi, Damla Çetinkaya Tezer, Serkan Demi. Seizures in inflammatory demyelinating disorders of the central nervous system. Multiple sclerosis and related disorders. vol 85. 2024-03-07. PMID:38452647. multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) may be associated with acute symptomatic seizures and chronic epilepsy as well. 2024-03-07 2024-03-10 Not clear
Adam Goldman-Yassen, Azalea Lee, Grace Gombola. Leptomeningeal Enhancement in Pediatric Anti-Myelin Oligodendrocyte Glycoprotein Antibody Disease, Multiple Sclerosis, and Neuromyelitis Optica Spectrum Disorder. Pediatric neurology. vol 153. 2024-02-21. PMID:38382244. leptomeningeal enhancement in pediatric anti-myelin oligodendrocyte glycoprotein antibody disease, multiple sclerosis, and neuromyelitis optica spectrum disorder. 2024-02-21 2024-02-24 Not clear
Adam Goldman-Yassen, Azalea Lee, Grace Gombola. Leptomeningeal Enhancement in Pediatric Anti-Myelin Oligodendrocyte Glycoprotein Antibody Disease, Multiple Sclerosis, and Neuromyelitis Optica Spectrum Disorder. Pediatric neurology. vol 153. 2024-02-21. PMID:38382244. anti-myelin oligodendrocyte glycoprotein (mog) antibody disease (mogad) is a type of acquired demyelinating disease that is distinct from multiple sclerosis (ms) and aquaporin-4 antibody neuromyelitis optica spectrum disorder (aqp4-nmosd). 2024-02-21 2024-02-24 Not clear
Susanna Asseyer, Ofir Zmira, Laura Busse, Barak Pflantzer, Patrick Schindler, Tanja Schmitz-Hübsch, Friedemann Paul, Claudia Chie. Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGAD. Frontiers in neurology. vol 15. 2024-02-13. PMID:38343712. aquaporin-4-antibody-seropositive (aqp4-igg+) neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disorder (mogad) are relapsing neuroinflammatory diseases, frequently leading to chronic pain. 2024-02-13 2024-02-15 Not clear
Mengyuan Yao, Wenjing Wang, Jiali Sun, Tianshu Guo, Jiangping Bian, Fuyao Xiao, Yuanyuan Li, Hengri Cong, Yuzhen Wei, Xinghu Zhang, Jianghong Liu, Linlin Yi. The landscape of PBMCs in AQP4-IgG seropositive NMOSD and MOGAD, assessed by high dimensional mass cytometry. CNS neuroscience & therapeutics. vol 30. issue 2. 2024-02-09. PMID:38334017. data on peripheral blood mononuclear cells (pbmcs) characteristics of aquaporin-4 (aqp4)-igg seropositive neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) are lacking. 2024-02-09 2024-02-11 Not clear
Chiara Rocchi, Mirasol Forcadela, Patricia Kelly, Samantha Linaker, Emily Gibbons, Maneesh Bhojak, Anu Jacob, Shahd Hamid, Saif Hud. The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis. Multiple sclerosis (Houndmills, Basingstoke, England). 2024-01-23. PMID:38258822. isolated first episodes of longitudinally extensive transverse myelitis (letm) have typically been associated with neuromyelitis optica spectrum disorder (nmosd) or myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). 2024-01-23 2024-01-25 Not clear
Lei Wang, Ruihong Xia, Xiangliang Li, Jingli Shan, Shengjun Wan. Systemic inflammation response index is a useful indicator in distinguishing MOGAD from AQP4-IgG-positive NMOSD. Frontiers in immunology. vol 14. 2024-01-23. PMID:38259484. to identify reliable immune-inflammation indicators for distinguishing myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) from anti-aquaporin-4 immunoglobulin g (aqp4-igg)-positive neuromyelitis optica spectrum disorders (nmosd). 2024-01-23 2024-01-25 Not clear
Soumya S Yandamuri, Beata Filipek, Nikhil Lele, Inessa Cohen, Jeffrey L Bennett, Richard J Nowak, Elias S Sotirchos, Erin E Longbrake, Emily M Mace, Kevin C O'Conno. A Noncanonical CD56dimCD16dim/- NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases. Journal of immunology (Baltimore, Md. : 1950). 2024-01-22. PMID:38251887. neuromyelitis optica spectrum disorder (nmosd), myelin oligodendrocyte glycoprotein ab disease, and autoimmune myasthenia gravis (mg) are autoantibody-mediated neurologic conditions where autoantibodies can induce ab-dependent cellular cytotoxicity (adcc), a nk cell-mediated effector function. 2024-01-22 2024-01-24 Not clear
N L Sheremet, D D Eliseeva, A K Kalashnikova, M N Zakharov. [Typical and atypical optic neuritis]. Vestnik oftalmologii. vol 139. issue 6. 2024-01-18. PMID:38235645. demyelinating on can be idiopathic or be one of the symptoms of autoimmune demyelinating diseases of the central nervous system (cns) such as multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). 2024-01-18 2024-01-20 Not clear
Giordani Rodrigues Dos Passos, Tarso Adoni, Maria Fernanda Mendes, Douglas Kazutoshi Sat. Reshaping neuroimmunology: diagnosis and treatment in the era of precision medicine. Arquivos de neuro-psiquiatria. vol 81. issue 12. 2023-12-29. PMID:38157878. this review explores the impact of precision medicine on various neuroimmunological conditions, including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), optic neuritis, autoimmune encephalitis, and immune-mediated neuropathies. 2023-12-29 2024-01-05 Not clear